Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 12,080 | 15,690 | 21,845 | 12,026 | 4,196 |
| Operating Income | -12,080 | -15,690 | -21,845 | -12,026 | -4,196 |
| Interest Expense | 104 | 0 | 0 | 93 | 148 |
| Other Income | 117 | 500 | 194 | 62 | 4 |
| Pre-tax Income | -12,067 | -15,190 | -21,651 | -12,056 | -4,340 |
| Net Income Continuous | -12,067 | -15,190 | -21,651 | -12,056 | -4,340 |
| Net Income | $-12,067 | $-15,190 | $-21,651 | $-12,056 | $-4,340 |
| EPS Basic Total Ops | -71.00 | -324.25 | -462.25 | -452.50 | -350.00 |
| EPS Basic Continuous Ops | -70.91 | -324.22 | -462.22 | -451.38 | -349.13 |
| EPS Diluted Total Ops | -71.00 | -324.25 | -462.25 | -452.50 | -350.00 |
| EPS Diluted Continuous Ops | -70.91 | -324.22 | -462.22 | -451.38 | -349.13 |
| EPS Diluted Before Non-Recurring Items | -71.00 | -324.25 | -462.50 | -452.50 | -350.00 |
| EBITDA(a) | $-12,080 | $-15,690 | $-21,845 | $-12,026 | $-4,196 |